Skip to main content
SpringerLink
Log in

Hypertrophie ohne Hypertonie

Hypertrophy without hypertension

  • Wie lautet Ihre Diagnose?
  • Published:
Der Kardiologe Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1
Abb. 2
Abb. 3
Abb. 4

Abbreviations

AL:

Amyloidose Leichtketten-Typ

ANS:

autonomes Nervensystem

ATTR:

Amyloidose Transthyretin-Typ

CMR:

kardiale Magnetresonanztomographie

GIT:

Gastrointestinaltrakt

HF:

Herzfrequenz

LGE:

„Late gadolinium enhancement“

LV:

linker Ventrikel

Met:

Methionin (Aminosäure)

NYHA:

New York Heart Association

PNP:

Polyneuropathie

PNS:

peripheres Nervensystem

RR:

Riva-Rocci

SSA:

senile systemische Amyloidose

Val:

Valin (Aminosäure)

Literatur

  1. Desport E, Bridoux F, Sirac C et al (2012) AL Amyloidosis. Orphanet J Rare Dis 7:54

    Article  PubMed Central  PubMed  Google Scholar 

  2. Dispenzieri A, Gertz MA, Kyle RA et al (2004) Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis. J Clin Oncol 22:3751–3757

    Article  CAS  PubMed  Google Scholar 

  3. Sharma N, Howlett J (2013) Current state of cardiac amyloidosis. Curr Opin Cariol 28:242–248

    Article  Google Scholar 

  4. Kristen AV, Giannitsis E, Bauer A et al (2007) Kardiale Amyloidose. Kardiologe 1:123–138

    Article  Google Scholar 

  5. Parsai C, O’Hanlon R, Prasad S et al (2012) Diagnostic and prognostic value of cardiovascular magnetic resonance in non-ischaemic cardiomyopathies. J Cardiovasc Magn Reson 14:54

    Article  PubMed Central  PubMed  Google Scholar 

  6. Gafni J, Sohar E (1960) Rectal biopsy for the diagnosis of amyloidosis. Am J Med Sci 240:332–336

    Article  CAS  PubMed  Google Scholar 

  7. Dubrey SW (2012) Amyloid heart disease: a brief review of treatment options. Postgrad Med J 88:700–705

    Article  PubMed  Google Scholar 

  8. Rubinow A, Skinner M, Cohen AS (1981) Digoxin sensitivity in amyloid cardiomyopathy. Circulation 63:1285–1288

    Article  CAS  PubMed  Google Scholar 

  9. Falk RH, Comenzo RL, Skinner M (1997) The systemic amyloidoses. N Engl J Med 337:898–900

    Article  CAS  PubMed  Google Scholar 

Download references

Einhaltung ethischer Richtlinien

Interessenkonflikt. I. Just, J. Fritzsche, K. Wassilew und R. Gebker geben an, dass kein Interessenkonflikt besteht. Dieser Beitrag beinhaltet keine Studien an Menschen oder Tieren.

Author information

Authors and Affiliations

  1. Klinik für Innere Medizin/Kardiologie, Deutsches Herzzentrum Berlin, Augustenburger Platz 1, 13353, Berlin, Deutschland

    I.A. Just, J. Fritzsche & R. Gebker

  2. Arbeitsbereich Herzpathologie, Klinik für Herz-, Thorax- und Gefäßchirurgie, Deutsches Herzzentrum Berlin, Berlin, Deutschland

    K. Wassilew

Authors
  1. I.A. Just
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. Fritzsche
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. K. Wassilew
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. R. Gebker
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to I.A. Just.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Just, I., Fritzsche, J., Wassilew, K. et al. Hypertrophie ohne Hypertonie. Kardiologe 8, 467–471 (2014). https://doi.org/10.1007/s12181-014-0610-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12181-014-0610-z

Search

Navigation